Reply: SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival

J. S Thompson Coon; Z. Liu; M. Hoyle; G. Rogers; C. Green; T. Moxham; K. Welch; K. Stein

doi:10.1038/sj.bjc.6605447

Reply: SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival

J. S Thompson Coon, Z. Liu, M. Hoyle, G. Rogers, C. Green, T. Moxham, K. Welch, K. Stein

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	234-235
Number of pages	2
Journal	British Journal of Cancer
Volume	102
Issue number	1
DOIs	https://doi.org/10.1038/sj.bjc.6605447
Publication status	Published - Jan 2010
Externally published	Yes

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.bjc.6605447

Cite this

@article{2077067841564c5b80fb5b88263c8f45,

title = "Reply: SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival",

author = "Coon, {J. S Thompson} and Z. Liu and M. Hoyle and G. Rogers and C. Green and T. Moxham and K. Welch and K. Stein",

year = "2010",

month = jan,

doi = "10.1038/sj.bjc.6605447",

language = "English",

volume = "102",

pages = "234--235",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Cancer Research UK",

number = "1",

}

TY - JOUR

T1 - Reply

T2 - SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival

AU - Coon, J. S Thompson

AU - Liu, Z.

AU - Hoyle, M.

AU - Rogers, G.

AU - Green, C.

AU - Moxham, T.

AU - Welch, K.

AU - Stein, K.

PY - 2010/1

Y1 - 2010/1

UR - http://www.scopus.com/inward/record.url?scp=74249084062&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605447

DO - 10.1038/sj.bjc.6605447

M3 - Article

AN - SCOPUS:74249084062

SN - 0007-0920

VL - 102

SP - 234

EP - 235

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 1

ER -